1. Home
  2. TWN vs NYXH Comparison

TWN vs NYXH Comparison

Compare TWN & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWN
  • NYXH
  • Stock Information
  • Founded
  • TWN 1986
  • NYXH 2009
  • Country
  • TWN Hong Kong
  • NYXH Belgium
  • Employees
  • TWN N/A
  • NYXH N/A
  • Industry
  • TWN Trusts Except Educational Religious and Charitable
  • NYXH Medical/Dental Instruments
  • Sector
  • TWN Finance
  • NYXH Health Care
  • Exchange
  • TWN Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • TWN 305.8M
  • NYXH 231.0M
  • IPO Year
  • TWN N/A
  • NYXH 2021
  • Fundamental
  • Price
  • TWN $50.25
  • NYXH $6.24
  • Analyst Decision
  • TWN
  • NYXH Strong Buy
  • Analyst Count
  • TWN 0
  • NYXH 3
  • Target Price
  • TWN N/A
  • NYXH $15.00
  • AVG Volume (30 Days)
  • TWN 20.1K
  • NYXH 159.3K
  • Earning Date
  • TWN 01-01-0001
  • NYXH 08-18-2025
  • Dividend Yield
  • TWN 1.10%
  • NYXH N/A
  • EPS Growth
  • TWN N/A
  • NYXH N/A
  • EPS
  • TWN N/A
  • NYXH N/A
  • Revenue
  • TWN N/A
  • NYXH $5,793,306.00
  • Revenue This Year
  • TWN N/A
  • NYXH $144.57
  • Revenue Next Year
  • TWN N/A
  • NYXH $244.36
  • P/E Ratio
  • TWN N/A
  • NYXH N/A
  • Revenue Growth
  • TWN N/A
  • NYXH 2.94
  • 52 Week Low
  • TWN $25.22
  • NYXH $5.55
  • 52 Week High
  • TWN $41.51
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • TWN 75.28
  • NYXH 38.74
  • Support Level
  • TWN $47.76
  • NYXH $6.07
  • Resistance Level
  • TWN $50.49
  • NYXH $6.47
  • Average True Range (ATR)
  • TWN 0.58
  • NYXH 0.42
  • MACD
  • TWN 0.07
  • NYXH -0.01
  • Stochastic Oscillator
  • TWN 91.34
  • NYXH 19.01

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: